$1.070
-0.039 (-3.60%)Al cierre
Noticias de AIFF
Eventos de AIFF
Firefly Neuroscience Partners with NeuroSigma to Expand Access to Monarch eTNS System
Firefly Neuroscience and NeuroSigma announced a strategic partnership to expand clinician awareness of and access to NeuroSigma's Monarch eTNS System through Firefly's growing nationwide network of Evoke clinician customers. Under the partnership, Firefly will introduce the Monarch device to psychiatry, neurology and behavioral health practices that use its FDA 510(k)-cleared, AI-powered Evoke EEG/ERP platform.
Firefly Neuroscience and Next Health Announce Strategic Partnership
Firefly Neuroscience and Next Health, a global leader in health optimization and longevity, announced a strategic partnership to launch a precision cognitive health platform integrating Firefly's AI-powered, FDA-cleared EEG/ERP brain biomarker technology with personalized cognitive peptide protocols. The initiative aims to provide physicians with objective measures of brain function to help personalize, monitor, and optimize emerging cognitive therapies. The announcement follows last week's recommendation by an FDA Advisory Committee to add six therapeutic peptides, including Epitalon and Semax, to the list of bulk drug substances eligible for pharmacy compounding. The recommendation is not binding and requires further FDA action. The initiative is expected to leverage Next Health's expanding network of longevity clinics. The companies intend to collaborate on developing standardized clinical protocols integrating Firefly's FDA-cleared EEG/ERP platform with provider-guided peptide therapies.
Firefly Neuroscience Files to Sell 22.5M Shares of Common Stock
Firefly Neuroscience files to sell 22.5M shares of common stock for holders
Emergent BioSolutions Secures $54M Government Contract
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly.TECH PANEL:President Trump has named MetaCEO Mark Zuckerberg, OracleExecutive Chairman Larry Ellison, NvidiaCEO Jensen Huang, and others to the Council of Advisors on Science and Technology, co-chaired by David Sacks, The Wall Street Journal's Annie Linksey and Alex Leary. The President's Council of Advisors on Science and Technology will advise on AI policy and emerging tech issues. "The United States has the opportunity to lead the world in AI," said Zuckerberg in a statement to The Wall Street Journal. "I'm honored to join the President's council and work with other industry leaders to help make this happen."AIRPORT MESS:President Donald Trumpvia Truth Social that, "Blame the Democrats for the Airport's mess. They want our Country to do badly. They want our Country to fail. They broke the already signed Bill because they want to take care of Criminals who enter our Country illegally, rather than American citizens. Thank you to our great ICE Patriots for helping. It makes a big difference. I may call up the National Guard for more help. President DJT." Publicly traded companies in the space include Alaska Air, American Airlines, Delta Air Lines, Frontier Group, JetBlue, Southwest, Sun Country Airlinesand United Airlines.AGENTIC OPERATING SYSTEM:Salesforceannounced the deployment of a new agentic operating system to simplify incident response and improve Veteran care across its more than 150 Department of Veterans Affairs, VA, medical and outpatient centers. By combining Salesforce's real-time data insights, integrated service, and complaint healthcare capabilities into a single, AI-powered operating system in Slack, the VHA is transitioning from static reporting to automated problem-solving that eliminates administrative silos and accelerates front-line Veteran care. This strategy enables the VHA to cut costs, streamline facility operations, and simplify services across facilities nationwide.DEPARTMENT OF WAR PARTNERSHIP:Firefly Neuroscienceannounced a partnership with the Department of War to support the assessment and treatment of active-duty U.S. service members and veterans suffering from Post-Traumatic Stress Disorder and/or Traumatic Brain Injury. The genesis of this public-private brain health partnership was initial work by the founders of Evoke Neuroscience with the U.S. Naval Medical Center Camp Lejeune Family Medicine Residency program. Specific details of the partnership and related programs remain confidential in accordance with applicable agreements.GOVERNMENT CONTRACTS:Emergent BioSolutionsannounced it has secured a contract award valued at approximately $54M to deliver CNJ-016 to the Administration for Strategic Preparedness and Response, or ASPR, part of the U. S. Department of Health and Human Services, or HHS, for smallpox preparedness. ASPR exercised an option from its existing 10-year contract for additional doses of VIGIV, a treatment for complications due to smallpox vaccination. In addition, Emergent has secured new incremental orders with an international government partner valued at $6.6M. This represents product orders for ACAM2000 within Emergent's medical countermeasures portfolio and will support the partner's smallpox biodefense strategy. These orders stem from a recurring international customer and demonstrate the importance of threat preparedness around the world.
Firefly Neuroscience Partners with Department of Defense for PTSD Assessment
Firefly Neuroscience announced a partnership with the Department of War to support the assessment and treatment of active-duty U.S. service members and veterans suffering from Post-Traumatic Stress Disorder and/or Traumatic Brain Injury. The genesis of this public-private brain health partnership was initial work by the founders of Evoke Neuroscience with the U.S. Naval Medical Center Camp Lejeune Family Medicine Residency program. Specific details of the partnership and related programs remain confidential in accordance with applicable agreements.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.